Why it’s a good year for diagnostics startups
Venture capitalists have typically shied away from investing in diagnostics. That mentality has changed, and a GE Ventures executive explains why.
Illumina embarks on its own next-gen journey
With a new tumor profiling panel, Illumina continues its transformation from a research tools provider to a genetic healthcare company.
Solving Healthcare’s Provider Data Problem Starts with Interoperability
Break down the silos. Take control of your provider data.